Alma Hybrid FemiLift Feminine Wellness Treatment
Africa's First Alma Hybrid FemiLift
Because The Future Is Feminine
Africa's First Alma Hybrid FemiLift
Because The Future Is Feminine

For the first time in Africa, S & S Aesthetics is harnessing the advanced technology of Alma Hybrid FemiLift to offer a new generation of feminine wellness treatments.

Designed to address both intimate aesthetic concerns and a range of feminine health and wellness indications, Vaguvination™ offers women a discreet, medically guided approach to restoring tissue quality, improving intimate comfort and enhancing confidence.

Your intimate wellness deserves the same level of innovation as the rest of you.

Alma Prime X at a Glance

The Next Generation Of Feminine Wellness in Africa

We are proud to be the first plastic surgery & medical aesthetic clinic to offer the Alma Hybrid FemiLift technology in Africa.
Book A Consultation
What Can Alma Hybrid FemiLift Help With?

Vaguvenation Lightening (Hybrid/ClearLift)

For women concerned about uneven or darker pigmentation in the intimate area.

Vaguvination Lightening is designed to address the appearance of unwanted pigmentation and support a more even-looking intimate area.

Your practitioner will assess your skin and determine whether laser lightening is appropriate for you and which treatment approach is most suitable.

For confidence in your own skin, everywhere.

*Requires consultation to advise on the best protocols to suit the patient.

Vaguvenation Lifting

For women experiencing changes in intimate tissue tone, elasticity or laxity.

Vaguvination Lifting uses advanced laser energy to stimulate tissue remodelling and collagen production, helping to support improved tissue quality and firmness.

It may be particularly relevant following childbirth, with age-related changes or where hormonal changes have affected intimate tissue.

Feel more comfortable. Feel more confident.

*Requires consultation to advise on the best protocols to suit the patient.

FEMININE WELLNESS GOES BEYOND AESTHETICS
FEMININE WELLNESS GOES BEYOND AESTHETICS

FemiLift isn’t simply about how intimate tissue looks. It has been developed to address a range of feminine health and wellness indications, including:

GENITOURINARY SYNDROME OF MENOPAUSE

Also known as GSM, Genitourinary Syndrome of Menopause can occur as declining oestrogen levels affect the vaginal and urinary tissues.

Symptoms may include:

  • Vaginal dryness
  • Burning or irritation
  • Itching
  • Vaginal discomfort
  • Pain or discomfort during intercourse
  • Changes in tissue quality
  • Urinary symptoms

FemiLift has been clinically studied for symptoms associated with GSM, with Alma reporting improvements in dryness, itching, burning and discomfort during intercourse.

Additional Feminine Wellness Concerns

VULVOVAGINAL ATROPHY

Hormonal changes, particularly around and after menopause, can affect the thickness, elasticity and health of vulvovaginal tissues.

FemiLift’s fractional CO₂ technology is designed to stimulate tissue remodelling and support improved tissue quality.

STRESS URINARY INCONTINENCE

Changes associated with childbirth, ageing and hormonal changes can contribute to stress urinary incontinence.

FemiLift is also indicated for the treatment of symptoms associated with stress urinary incontinence and has been clinically studied in this area.

VAGINAL LAXITY & TISSUE ELASTICITY

Changes in vaginal tissue can occur following childbirth, ageing and hormonal changes.

FemiLift’s thermal and fractional CO₂ effects are designed to stimulate tissue regeneration and collagen production, supporting tissue quality and elasticity.

Pricing for Vaguvenation Treatments
  • Per Session
  • Vaguvenation Lightening R11 999
  • Per Session
  • Vaguvenation Lifting R11 999

Book Your

Consultation

Fall in love with your skin again by booking a treatment or consultation with our experts at S & S Aesthetics

*Please note that treatments with medical doctors must be requested specifically during your booking, and may incur an additional consultation fee.